Dental approach to pediatric patients receiving chemotherapy

Yıl 2014, , 154 - 9, 08.09.2014

Özge Özmekik İşın Ulukapı

https://doi.org/10.17214/aot.04699

Cited By: 2

Öz

The increase in the prevalence of cancer in children has been accompanied by an expanded use of chemotherapy. The chemotherapeutic agents can cause a variety of oral complications. This article aims to present the dental problems that may occur in children with cancer and receiving chemotherapy and the importance of oral health care in these patients.

Anahtar Kelimeler

Chemotherapy, Infection, Mucositis, Oral Health, Pediatric Dentistry, Xerostomia

Kemoterapi alan çocuklarda diş hekimliği yaklaşımı

Öz

Çocuklarda kanser prevalansındaki artış kemoterapinin daha yaygın kullanımını beraberinde getirmektedir. Tedavi için kullanılan kemoterapötik ajanlar da ağızda çeşitli komplikasyonlara neden olabilmektedir. Bu makalenin amacı, kemoterapi alan kanserli çocuklarda dişlerde oluşabilecek problemler ve ağız bakımının önemini belirtmektir.

Anahtar Kelimeler

Ağız Sağlığı, Çocuk Diş Hekimliği, Enfeksiyon, Kemoterapi, Kserostomi, Mukozit

Kaynakça

• Kutluk T. Çocukluk çağı kanserlerinin epidemiyolojisi ve Türkiye’deki durum. Turkiye Klinikleri J Pediatr Sci 2009;5:1-8.
• Stiller C, Quinn M, Rowan S. The health of children and young people. Childhood cancer. 1st ed. London: Office for National Statistics; 2004. p.1-19.
• Tanyeli A, Kılınç Y, Erkman H, Antmen B, Serbest M, Korabay A, et al. Çukurova Bölgesinde çocukluk çağı malignensleri. Çukurova Üniversitesi Tıp Fakültesi Dergisi 1995;3:157-61.
• Tarbell NJ, Kooy HM. General principles of radiation oncology. Pizzo PA, Poplack DG, eds. Principles and practice of pediatric oncology. 4th ed. Philedelphia: Lippincott Williams and Wilkins; 2002. p.135-78.
• Adamson PC, Balis FM, Berg S, Blarey SM. General principles of chemotheraphy. In: Pizzo PA, Poplack DG, eds. Principles and practice of pediatric oncology. 5th ed. Philedelphia: Lippincott Williams and Wilkins; 2006. p.290-365.
• Goho C. Chemoradiation therapy: effect on dental development. Pediatr Dent 1993;15:6-12.
• Bergmann OJ. Oral infections and fever in immunocompromised patients with haematologic malignancies. Eur J Clin Microbiol Infect Dis 1989;8:207-13.
• Bergmann OJ. Oral infections and septicemia in immunocompromised patients with hematologic malignancies. J Clin Microbiol 1988;26:2105-9.
• Council on Clinical Affairs. Clinical guideline on the dental management of pediatric patinets receiving chemotheraphy, bone marrow transplantation and/or radiation. American Academy of Pediatric Dentistry 2001;5:82-4.
• da Fonseca MA. Dental care of the pediatric cancer patient. Pediatr Dent 2004;26:53-7.
• Schubert MM, Epstein JB, Peterson DE. Oral complications of cancer theraphy. Yagiela JA, Dound FJ, Neidle EA, eds. Pharmacology and therapeutics for dentistry. 4th ed. St. Louis: Mosby-Year Book; 1998. p. 644-55.
• Kambek S, Akal N. Kemoterapi alan çocuklarda diş hekimliği yaklaşımı. Cumhuriyet Üniversitesi Diş Hekimliği Fakültesi Dergisi 2000;3:52-7.
• Clinical Affairs Committee. Clinical Guideline on Dental Management of Pediatric Patients Receiving Chemotheraphy, Hematopoetic Cell Transplantation, and/or Radiation. Chicago: The American Academy of Pediatric Dentistry; 2008. p.253-8.
• Sheller B, Williams B. Orthodontic management of patients with hematologic malignancies. Am J Orthod Dentofacial Orthop 1996;109:575-80.
• Little JW, Falace DA, Miller CS, Rhodus NL. Dental Management of the Medically Compromised Patient, 7th ed. St. Louis, Mosby; 2008. p. 433-61.
• Fulton JS, Middleton GJ, McPhail JT. Management of oral complications. Semin Oncol Nurs 2002;18:28-35.
• Peterson DE, Elias EG, Sonis ST. Head and Neck Management of the Cancer Patient, Boston, MA: Martinus Nijhoff Publishing; 1986. p. 401-27.
• Bonnaure-Mallet M, Bunetel L, Tricot-Doleux S, Guérin J, Bergeron C, LeGall E. Oral complications during treatment of malignant diseases in childhood: effects of tooth brushing. Eur J Cancer 1998;34:1588-91.
• Cheng KK, Molassiotis A, Chang AM, Wai WC, Cheung SS. Evaluation of an oral care protocol intervention in the prevention of chemotherapy-induced oral mucositis in paediatric cancer patients. Eur J Cancer 2001;37:2056-63.
• Sonis S, Clark J. Prevention and management of oral mucositis induced by antineoplastic therapy. Oncology (Williston Park) 1991;5:11-8; discussion 18-22.
• Oliff A, Bleyer WA, Poplack DG. Methotrexate-induced oral mucositis and salivary methotrexate concentrations. Cancer Chemother Pharmacol 1979;2:225-6.
• Schilsky RL, Milano GA, Ratain MJ. Principles of antineoplastic drug development and pharmacology. In: Weitman S, Kamen BA, eds. Cancer Chemotherapy and Pharmocology in Children. New York: Marcel Dekker; 1996. p.375-92.
• Çubukçu Elbek Ç. Pediatrik kanser hastalarında oral mukozit ve ağız sağlığı. Güncel Pediatri 2005;3:67-9.
• Dreizen S. Oral complications of cancer therapies. Description and incidence of oral complications. NCI Monogr 1990;9:11-5.
• Dale RA, Harrison JS, Redding SW. Oral complications in cancer chemotherapy, cancer incidence, and mortality in the U.S. Gen Dent 2004;52:64-71; quiz 72.
• Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, et al.; Mucositis Study Section of the Multinational Association for Supportive Care in Cancer; International Society for Oral Oncology. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 2004;100:1995-2025.
• Mealey BL, Semba SE, Hallmon WW. Dentistry and the cancer patient: Part 1--Oral manifestations and complications of chemotherapy. Compendium 1994;15:1252, 1254, 1256 passim; quiz 1262.
• Yavas Ö, Hakkı SS. Onkoloji hastalarında oral komplikasyonlar ve dental yaklaşım. Hacettepe Üniversitesi Diş Hekimliği Dergisi 2005;29:58-67.
• Çankaya H. Kemoterapi sonucu gözlenen oral değişiklikler ve tedavi yaklaşımları. EÜ Dişhek Fak Derg 2001;22:103-8.
• Ord RA, Blanchaert RH Jr. Current management of oral cancer. A multidisciplinary approach. J Am Dent Assoc 2001;132 Suppl:19S-23S.
• Fayle SA, Curzon ME. Oral complications in pediatric oncology patients. Pediatr Dent 1991;13:289-95.
• Balis FM, Holcenberg JS, Blarey SM. General principles of chemotheraphy. Pizzo PA, Poplack DG, eds. Principles and practice of pediatric oncology. 4th ed. Phidelphia: Lippincott Williams and Wilkins; 2002. p.369-80.
• Dahllöf G, Jönsson A, Ulmner M, Huggare J. Orthodontic treatment in long-term survivors after pediatric bone marrow transplantation. Am J Orthod Dentofacial Orthop 2001;120:459-65.
• Koppang HS. Histomorphologic investigations on the effect of cyclophosphamide on dentinogenesis of the rat incisor. Scand J Dent Res 1973;81:383-96.
• Krishnan V, Davidovitch Z. The effect of drugs on orthodontic tooth movement. Orthod Craniofac Res 2006;9:163-71.
• Kaste SC, Hopkins KP, Bowman LC, Santana VM. Dental abnormalities in children treated for neuroblastoma. Med Pediatr Oncol 1998;30:22-7.
• Nunn JH, Welbury RR, Gordon PH, Kernahan J, Craft AW. Dental caries and dental anomalies in children treated by chemotherapy for malignant disease: a study in the north of England. Int J Paediatr Dent 1991;1:131-5.
• Alpaslan G, Alpaslan C, Gögen H, Oğuz A, Cetiner S, Karadeniz C. Disturbances in oral and dental structures in patients with pediatric lymphoma after chemotherapy: a preliminary report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;87:317-21.
• Hutton A, Bradwell M, English M, Chapple I. The oral health needs of children after treatment for a solid tumour or lymphoma. Int J Paediatr Dent 2010;20:15-23.